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Imagine you have spent many years
trying to develop new techniques
that could one day cure cardiac
disease, cancer or Parkinson’s
disease, you finally arrive at the point
where it appears logical to move up
from mice to human cell cultures,
only to find yourself accused of
‘cannibalism’ by an archbishop
preaching one of the year’s most
important masses at Cologne
cathedral. Unbelievable? It
happened in Germany in early June,
when the discussion about the
possible use of embryonic stem (ES)
cells boiled over. The potential
benefits of the technique, which had
been obvious since human ES cells
were first reported in November
1998, suddenly vanished behind a
barrage of criticism.
According to the embryo
protection law
(Embryonenschutzgesetz), researchers
in Germany are not allowed to
produce stem cells from ‘spare’
embryos left over after IVF
treatment, as this would require a
six-day-old embryo to be destroyed.
Although this blastocyst is only a ball
of just over 100 perfectly
undifferentiated cells, which in the
womb may or may not succeed in
establishing a pregnancy, and could
be legally aborted for another eleven
weeks if it does, the law sees it as
alive from the moment of
fertilization. (Strangely, it is perfectly
legal to throw that very same embryo
in the dustbin, where it will die just
as certainly.) There is a loophole,
however, as current legislation
cannot stop German researchers
from ordering stem cells out of the
cell lines produced in the US,
Australia, and Israel, and using them
for their research in Germany. 
This is what the heart specialist
Wolfgang-Michael Franz was hoping
to do last year at the University of
Lübeck. Having demonstrated the
production of functional heart cells
from mouse ES cells, he wanted to
apply his method to human cells and
ordered ES cells from the company
WiCell in Madison, Wisconsin.
Stunned scientists have shelved
their plans awaiting political
decisions from funding agencies
and the government
By the time the material arrived
at Lübeck in May this year, Franz
had moved to a hospital at Munich.
The cells were put in the freezer and
very nearly forgotten, until a camera
team from the most influential TV
news programme found them at the
beginning of July. 
In the face of a heated public debate
which has culminated in criticism
placing stem cell researchers in the
uncomfortable neighbourhood of Drs
Frankenstein and Mengele, stunned
scientists have shelved their plans
awaiting political decisions from
funding organizations and the
government. One part of the problem
is the lack of an established advisory
body that could help politicians on
such tricky questions. A national
ethics board has only been
established a few months ago, but of
its members, only the geneticist
Ernst-Ludwig Winnacker, president
of the major funding agency DFG,
has spoken out on the ES cell
debate. There is no national academy
of science comparable to the Royal
Society or the French and US
academies. True to the federal
tradition of German administration,
there are regional scientific
academies, whose leaders have so far
failed to come up with a consensus
on how a unified body at the national
level could improve the
communication between science and
politics. Individual voices from
various parts of the life sciences —
clearly fearing that a more general
backlash against biomedical research
would affect areas so far exempt from
criticism — have called for a
voluntary moratorium on the use of
ES cells until a legal framework has
been created. Some also fear that
maverick researchers would try to use
stem cell research as a gateway to
cloning humans. However, an
outright ban on the import has been
declared both unacceptable and
impossible to police. 
Thus, all eyes are turning
towards the Berlin parliament
(Bundestag), which is expected to
make a decision on the use of
imported stem cells this autumn.
The political problem here is that
the issue splits both the red-green
coalition government and the
conservative opposition. The
conservative parties CDU and CSU
represent some very strict catholic
parts of the population who would
follow the above quoted archbishop
in condemning any research that has
anything to do with human embryos.
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However, these parties also include
people who blindly believe the
promises of any new technology and
are happy to impose it against strong
opposition. The liberal democrats
(FDP) are mostly in favour of
allowing research with ES cells and
want to speed up the parliamentary
process, the Green party is mostly
against giving researchers more
freedom, but has also turned down
the CDU’s call for a ban on imports.
Chancellor Gerhard Schröder’s social
democrats are split between the
positions of research minister
Edelgard Bulmahn (for stem cell
research) and justice minister Herta
Däubler-Gmelin (against). Hence,
only the most ardent proponents of
both extremes are keen on this
debate, while most party officials are
afraid to see the rifts within their
own party exposed. When the issue
comes up for parliamentary debate
in autumn, the final outcome will
be open. 
Considering that the spectre of
the Nazi experiments on human
subjects and their views on selection
of the fittest is one of the main
ethical crunch points in the German
debate (particularly for skeptics in
the red-green coalition), it appears
paradoxical that the country most
entitled to such worries, Israel, has
thrown them overboard and
embraces stem cell research more
enthusiastically than almost any
other nation. 
Leading voices of science ethics
in Israel are in agreement that,
according to Judaism, an early phase
human embryo does not merit more
protection than a sperm or egg cell.
One wouldn’t want to waste a
potential human being, but it is
acceptable to use it for a good cause
such as health research or
reproduction. Such religiously based
statements on scientific issues
dominate both public opinion and
political decisions in areas such as in
reproduction medicine, surrogate
motherhood, or cloning.
Surprisingly, the resulting policies
tend to be more permissive of the
application of new biomedical
techniques than those in countries
deriving their ethical framework
from Christianity. 
Thus, the Israeli Joseph
Itskovitz-Eldor was inhibited neither
by religious nor by political concerns
when he became involved in the
creation of both the very first human
ES stem cell line — which was
reported in Science in November 1998
and is now in the care of the
company Geron at Menlo Park,
California — and later of another cell
line at his own workplace at the
Technion at Haifa. The Jerusalem Post
quotes him as saying that he expects
that the ES cells will make human
tissue repair possible within three to
five years. Therefore, he is keen to
spread the use of stem cells for
biomedical research by cooperation
with carefully selected laboratories in
other countries, and he is said to be
willing to collaborate with German
researchers such as the
neuropathologist Oliver Brüstle from
Bonn University, who recently
traveled to Haifa in the company of
the chief of his regional government,
Wolfgang Clement, to discuss such
possibilities. 
Before they can set to work,
however, some persuasion will be
required to change the political tide
in Germany. Currently, Brüstle is
under police protection around the
clock, following death threats made
against him. Many other researchers
whose work could involve stem cells
in the future have not dared to speak
out. Maybe Itskovitz-Eldor should
consider a return visit to Bonn to
help his colleague explain to the
German public that ES cell research
is about repairing damaged tissue,
not about eating children. 
Michael Gross is a science writer based at
the Oxford Centre for Molecular Sciences.
He can be contacted through his web page
at www.michaelgross.co.uk.
Cells of contention: An early human embryo,
which can provide a source of stem cells, fits
easily on the tip of a needle. But the
problems raised by such a potential are far
from microscopic. 
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